Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Total Body Irradiation Versus Chemotherapy-Only Conditioning in Autologous Hematopoietic Stem Cell Transplantation for Large B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 2224.

https://doi.org/10.1182/blood-2023-184728

Published: 2023

Journal Articles

Relative Prognostic Value of Flow Cytometric Measurable Residual Disease before Allogeneic Hematopoietic Cell Transplantation for Adults with MDS/AML or AML

Corentin Orvain, Naveed Ali, Megan Othus, Eduardo Rodríguez-Arbolí, Filippo Milano, Brenda M. Sandmaier, Bart L. Scott, Frederick R. Appelbaum, Roland B. Walter

Blood (2023) 142 (Supplement 1): 4315.

https://doi.org/10.1182/blood-2023-188633

Published: 2023

Journal Articles

Role of Measurable Residual Disease (MRD) Testing for the Prediction of Late Relapses Following Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia

Naveed Ali, Othus Megan, Eduardo Rodríguez-Arbolí, Corentin Orvain, Filippo Milano, Brenda M. Sandmaier, Chris Davis, Ryan S. Basom, Frederick R. Appelbaum, Roland B. Walter

Blood (2023) 142 (Supplement 1): 4308.

https://doi.org/10.1182/blood-2023-183117

Published: 2023

Journal Articles

Final Results of a Dual-Institution Phase I Clinical Trial of Targeted Marrow Irradiation (TMI) Intensification of Reduced-Intensity Fludarabine/Busulfan (Flu/Bu) Conditioning for Allogeneic Hematopoietic Cell Transplantation for Medically Frail Patients with High-Risk Hematological Malignancies

Naveed Ali, MD, Ana Carolina Pires de Rezende, MD, Folashade Otegbeye, MBBChir,MPH, Mariana Nassif Kerbauy, MD, Brenda W. Cooper, MD, David Mansur, MD, Gisele Pereira, PhD, Roberto Sakuraba, MD, Benjamin K. Tomlinson, MD, Kirsten M Boughan, DO, Cinthya Correa Silva, MD, Leland Metheny, III, MD, Andreza Feitosa Ribeiro, MD, Molly M Gallogly, MDPhD, Ehsan Malek, MD, EDuardo Weltman, MD, Marcos de Lima, MD, Nelson Hamerschlak, MD PhD, Paolo F Caimi, MD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-142197

Published: 2020

Journal Articles

Low Dose Daily Corticosteroid Tapering Regimen Allows Highly Effective and Practical Desensitization for Multiple Myeloma Patients with Skin Rash after Immunomodulatory Drugs

Amin Firoozmand, MD, Naveed Ali, MD, Nausheen Ahmed, MD, Pingfu Fu, Shufen Cao, George Brown, Hannah Schmikla, RN, James J. Driscoll, MD PhD, Timothy O'Brien, Paolo Caimi, MD, Marcos de Lima, MD, Ehsan Malek, MD

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-140800

Published: 2020

Journal Articles

Disease and Patient Characteristics, Patterns of Care, Toxicities, and Outcomes of Chronic Lymphocytic Leukemia (CLL) Patients Treated with Venetoclax: A Multicenter Study of 204 Patients

Anthony R. Mato, MD, Constantine S. Tam, MBBS, MD FRACP, FRCPA, John N. Allan, MD, Danielle M. Brander, MD, John M. Pagel, MD PhD, Chaitra S. Ujjani, MD, Brian T. Hill, MD PhD, Nicole Lamanna, MD, Frederick Lansigan, MD, Ryan Jacobs, MD, Mazyar Shadman, MD, Alan P Skarbnik, MD, Jeffrey J. Pu, MD PhD, Paul M. Barr, MD, Alison R. Sehgal, MD, Bruce D. Cheson, MD, Clive S Zent, MD, Hande H. Tuncer, MD, Stephen J. Schuster, MD, Peter V. Pickens, MD, Nirav N Shah, MD, Allison M. Winter, MD, Kaitlin Kennard, RN, BSN, Krista Isaac, DO, MS, Colleen Dorsey, BSN, RN, Alexandra Marie Vandegrift, BA, Arun K Singavi, MD, Annalynn Williams, MS, Christina Howlett, PharmD, Hanna Weissbrot, BS, Naveed Ali, MD, Sirin Khajavian, MD, Andrea Sitlinger, MD, Eve Tranchito, BS, Joanna Rhodes, MD, Erica Bharat Bhavsar, BS, Neil Bailey, MS, Bhavisha Patel, MD, Timothy F. Burns, MD, Melissa Yacur, MD, Mansi Malhotra, BS, Sasanka Handunnetti, MD, Jakub Svoboda, MD, Richard R. Furman, MD, Chadi Nabhan, MD MBA, FACP

Blood (2017) 130 (Supplement 1): 4315.

https://doi.org/10.1182/blood.V130.Suppl_1.4315.4315

Published: 2017

Journal Articles

Front-Line Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) in the Real World: Responses, Toxicity, Outcomes and Subsequent Therapies

Anthony R. Mato, MD, John N. Allan, MD, John M. Pagel, MD PhD, Danielle M. Brander, MD, Brian T. Hill, MD PhD, Bruce D. Cheson, MD, Richard R. Furman, MD, Nicole Lamanna, MD, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Ryan Jacobs, MD, Frederick Lansigan, MD, Paul M. Barr, MD, Mazyar Shadman, MD, Alan P Skarbnik, MD, Douglas F. Beach, MD, Jeffrey J. Pu, MD PhD, Alison R. Sehgal, MD, Allison M. Winter, MD, Clive S Zent, MD, Hande H. Tuncer, MD, Arun K Singavi, MD, Stephen J. Schuster, MD, Peter V. Pickens, MD, Nirav N Shah, MD, Annalynn Williams, MS, Christina Howlett, PharmD, BCOP, Hanna Weissbrot, BS, Naveed Ali, MD, Bhavisha Patel, MD, Krista Isaac, DO, MS, Joanna Rhodes, MD, Mitchell E. Hughes, PharmD, BCPS, BCOP, Sirin Khajavian, MD, Elizabeth T Chatburn, BS, Andrea Sitlinger, MD, Eve Tranchito, BS, Erica Bharat Bhavsar, BS, Neil Bailey, MS, Timothy F. Burns, MD, Melissa Yacur, MD, Mansi Malhotra, BS, Sasanka Handunnetti, MD, Kaitlin Kennard, RN, BSN, Chadi Nabhan, MD MBA, FACP, Chaitra S. Ujjani, MD

Blood (2017) 130 (Supplement 1): 3011.

https://doi.org/10.1182/blood.V130.Suppl_1.3011.3011

Published: 2017

Journal Articles

Pulmonary Adverse Effects Associated with Tyrosine Kinase Inhibitor (TKI) Therapy in Patients with Chronic Myeloid Leukemia (CML)

Naveed Ali, MD, Jibran Durrani, MD, Mary Naglak, PhD, Jessica Berman, MD, Herbert Edward Auerbach, DO, Peter V. Pickens, MD

Blood (2017) 130 (Supplement 1): 5258.

https://doi.org/10.1182/blood.V130.Suppl_1.5258.5258

Published: 2017

Journal Articles

Impact of BCR-ABL Transcript Subtypes in Achieving Major Molecular Remission in Chronic Phase, Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Naveed Ali, MD, Mary Naglak, PhD, Herbert Edward Auerbach, DO, Jessica Berman, MD, Peter V. Pickens, MD

Blood (2017) 130 (Supplement 1): 5246.

https://doi.org/10.1182/blood.V130.Suppl_1.5246.5246

Published: 2017

Journal Articles

Optimizing Autologous Stem Cell Transplant for High-Risk Patients with Plasma Cell Dyscrasias

Naveed Ali, MD, Brenda W. Cooper, MD, Merle Kolk, Richard Creger, PhD, Gina Hoffman, Hillard M Lazarus, MD, Ben K. Tomlinson, MD, Paolo Caimi, MD, Leland Metheny, MD, Marcos de Lima, MD, Ehsan Malek, MD

Blood (2017) 130 (Supplement 1): 5656.

https://doi.org/10.1182/blood.V130.Suppl_1.5656.5656

Published: 2017

NARROW

Total Body Irradiation Versus Chemotherapy-Only Conditioning in Autologous Hematopoietic Stem Cell Transplantation for Large B-Cell Lymphoma

Relative Prognostic Value of Flow Cytometric Measurable Residual Disease before Allogeneic Hematopoietic Cell Transplantation for Adults with MDS/AML or AML

Role of Measurable Residual Disease (MRD) Testing for the Prediction of Late Relapses Following Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia

Final Results of a Dual-Institution Phase I Clinical Trial of Targeted Marrow Irradiation (TMI) Intensification of Reduced-Intensity Fludarabine/Busulfan (Flu/Bu) Conditioning for Allogeneic Hematopoietic Cell Transplantation for Medically Frail Patients with High-Risk Hematological Malignancies

Low Dose Daily Corticosteroid Tapering Regimen Allows Highly Effective and Practical Desensitization for Multiple Myeloma Patients with Skin Rash after Immunomodulatory Drugs

Disease and Patient Characteristics, Patterns of Care, Toxicities, and Outcomes of Chronic Lymphocytic Leukemia (CLL) Patients Treated with Venetoclax: A Multicenter Study of 204 Patients

Front-Line Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) in the Real World: Responses, Toxicity, Outcomes and Subsequent Therapies

Pulmonary Adverse Effects Associated with Tyrosine Kinase Inhibitor (TKI) Therapy in Patients with Chronic Myeloid Leukemia (CML)

Impact of BCR-ABL Transcript Subtypes in Achieving Major Molecular Remission in Chronic Phase, Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Optimizing Autologous Stem Cell Transplant for High-Risk Patients with Plasma Cell Dyscrasias

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only